Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations

被引:22
作者
Camou, T
Palacio, R
Di Fabio, JL
Hortal, A
机构
[1] Minist Hlth, Maternal Child Dept, Montevideo 11300, Uruguay
[2] Natl Reference Lab, Montevideo, Uruguay
[3] HVP PAHO, Washington, DC USA
关键词
Streptococcus pneumoniae serotypes; invasive pneumococcal infections; conjugate vaccine;
D O I
10.1016/S0264-410X(02)00806-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An on-going Streptococcus pneumoniae surveillance in Uruguay furnished national information on serotype distribution of isolates from invasive infections in children less than or equal to5 years. The adequacy of 7-, 9- and 11-valent conjugate vaccine formulations was evaluated, in comparison with the prevalence of the serotypes causing disease in this target population. From 1994 to 2001, 506 isolates were submitted to the National Reference Laboratory. The heptavalent vaccine would cover 49% of the invasive isolates, while the nonavalent vaccine would potentially prevent 76% of cases. The 11-valent vaccine would increase coverage to 86%. All the serotype/groups of penicillin-resistant isolates are included in the three conjugate vaccine formulations. The available data indicate that the 9- or the 11-valent vaccines, if affordable, are the most suitable formulations for Uruguayan children. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2093 / 2096
页数:4
相关论文
共 15 条
[1]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[2]  
BUTLER JC, 1999, MOL BIOL MECH DIS, P479
[3]   Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999 [J].
Di Fabio, JL ;
Castañeda, E ;
Agudelo, CI ;
De la Hoz, F ;
Hortal, M ;
Camou, T ;
Echániz-Avilés, G ;
Barajas, MNC ;
Heitmann, I ;
Hormazabal, JC ;
Brandileone, MCC ;
Vieira, VSD ;
Regueira, M ;
Ruvinski, R ;
Corso, A ;
Lovgren, M ;
Talbot, JA ;
De Quadros, C .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (10) :959-967
[4]   Pan American Health Organization Epidemiological Surveillance Network for Streptococcus pneumoniae [J].
DiFabio, JL ;
Homma, A ;
DeQuadros, C .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (02) :131-133
[5]  
Groseclose S. L., 2000, Morbidity and Mortality Weekly Report, V49, P1
[6]   Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I [J].
Hausdorff, WP ;
Bryant, J ;
Paradiso, PR ;
Siber, GR .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :100-121
[7]   Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries:: 1993-1999 surveillance [J].
Hortal, M ;
Lovgren, M ;
De la Hoz, F ;
Agudelo, CI ;
Brandileone, MC ;
Camou, T ;
Casagrande, S ;
Castañeda, E ;
Corso, A ;
Echaniz, G ;
Hormazabal, JC ;
Pace, J ;
Palacio, R ;
Perez-Giffoni, G ;
Ruvinsky, R ;
Di Fabio, JL .
MICROBIAL DRUG RESISTANCE, 2001, 7 (04) :391-401
[8]  
HORTAL M, 1990, REV INFECT DIS, V12, pS915
[9]   Invasive Streptococcus pneumoniae infection in Latin American children:: Results of the Pan American Health Organization surveillance study [J].
Kertesz, DA ;
Di Fabio, JL ;
Brandileone, MCD ;
Castañeda, E ;
Echániz-Aviles, G ;
Heitmann, I ;
Homma, A ;
Hortal, M ;
Lovgren, M ;
Ruvinsky, RO ;
Talbot, JA ;
Weekes, J ;
Spika, JS .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) :1355-1361
[10]   Bacterial vaccines and serotype replacement:: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae [J].
Lipsitch, M .
EMERGING INFECTIOUS DISEASES, 1999, 5 (03) :336-345